🔗 Visit the ClinicalTrials.gov page for NCT01750281
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road. | Nat Rev Cancer | 2015 | 1.27 |
| 2 | MEK inhibition in non-small cell lung cancer. | Lung Cancer | 2014 | 1.05 |
| 3 | Targeted therapies in non-small cell lung cancer: emerging oncogene targets following the success of epidermal growth factor receptor. | Semin Oncol | 2013 | 1.03 |
| 4 | Experience with targeted next generation sequencing for the care of lung cancer: insights into promises and limitations of genomic oncology in day-to-day practice. | Cancer Treat Commun | 2015 | 0.99 |